Annual ROE
-63.32%
-0.66%-1.05%
December 31, 2023
Summary
- As of February 8, 2025, TLIS annual return on equity is -63.32%, with the most recent change of -0.66% (-1.05%) on December 31, 2023.
- During the last 3 years, TLIS annual ROE has fallen by -147.26% (-175.43%).
- TLIS annual ROE is now -148.72% below its all-time high of 129.96%, reached on December 31, 2019.
Performance
TLIS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-79.73%
-10.58%-15.30%
June 30, 2024
Summary
- As of February 8, 2025, TLIS quarterly return on equity is -79.73%, with the most recent change of -10.58% (-15.30%) on June 30, 2024.
- Over the past year, TLIS quarterly ROE has dropped by -14.96% (-23.10%).
- TLIS quarterly ROE is now -163.62% below its all-time high of 125.33%, reached on September 30, 2020.
Performance
TLIS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TLIS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -23.1% |
| 3 y3 years | -175.4% | -26.0% |
| 5 y5 years | -254.3% | -26.0% |
TLIS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.1% | +22.9% | -36.8% | at low |
| 5 y | 5-year | -148.7% | +22.9% | -163.6% | +66.5% |
| alltime | all time | -148.7% | +22.9% | -163.6% | +66.5% |
Talis Biomedical ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -79.73%(+15.3%) |
| Mar 2024 | - | -69.15%(+7.9%) |
| Dec 2023 | -63.32%(+1.1%) | -64.10%(-3.7%) |
| Sep 2023 | - | -66.56%(+2.8%) |
| Jun 2023 | - | -64.77%(+1.9%) |
| Mar 2023 | - | -63.58%(+0.5%) |
| Dec 2022 | -62.66%(-23.7%) | -63.28%(+5.6%) |
| Sep 2022 | - | -59.90%(+2.8%) |
| Jun 2022 | - | -58.28%(-12.4%) |
| Mar 2022 | - | -66.55%(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -82.07%(-197.8%) | -67.21%(-35.2%) |
| Sep 2021 | - | -103.75%(-37.9%) |
| Jun 2021 | - | -167.11%(-29.8%) |
| Mar 2021 | - | -238.01%(-327.9%) |
| Dec 2020 | 83.94%(-35.4%) | 104.44%(-16.7%) |
| Sep 2020 | - | 125.33%(+5.7%) |
| Jun 2020 | - | 118.52%(+66.9%) |
| Mar 2020 | - | 71.00%(+96.6%) |
| Dec 2019 | 129.96%(+216.7%) | 36.12% |
| Dec 2018 | 41.03% | - |
FAQ
- What is Talis Biomedical annual return on equity?
- What is the all time high annual ROE for Talis Biomedical?
- What is Talis Biomedical annual ROE year-on-year change?
- What is Talis Biomedical quarterly return on equity?
- What is the all time high quarterly ROE for Talis Biomedical?
- What is Talis Biomedical quarterly ROE year-on-year change?
What is Talis Biomedical annual return on equity?
The current annual ROE of TLIS is -63.32%
What is the all time high annual ROE for Talis Biomedical?
Talis Biomedical all-time high annual return on equity is 129.96%
What is Talis Biomedical annual ROE year-on-year change?
Over the past year, TLIS annual return on equity has changed by -0.66% (-1.05%)
What is Talis Biomedical quarterly return on equity?
The current quarterly ROE of TLIS is -79.73%
What is the all time high quarterly ROE for Talis Biomedical?
Talis Biomedical all-time high quarterly return on equity is 125.33%
What is Talis Biomedical quarterly ROE year-on-year change?
Over the past year, TLIS quarterly return on equity has changed by -14.96% (-23.10%)